The company has reported net sales of $2.82 billion for the first quarter of 2009, a decrease of 2%, compared to $2.87 billion for the first quarter of 2008.
Robert Parkinson Jr, chairman and CEO of Baxter International, said: “Despite the challenging, global macro-economic environment, our first quarter financial results underscore the value of our diversified healthcare model, the solid fundamentals underpinning our portfolio, and our disciplined focus on driving margin improvement.
“We continue to believe that we are very well-positioned given our broad geographic reach and the medically-necessary nature of our portfolio to expand access to care, improve treatments and enhance the quality of life for patients around the world.”